New data challenge common beliefs about antihistamines, corticosteroids, and vaccines in chronic urticaria, with practical ...
With chronic urticaria on the rise, the CURE study calls for greater awareness on guideline-recommended classification, diagnostic workup, and treatment.
DelveInsight's“ Chronic Spontaneous Urticaria Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the Chronic Spontaneous Urticaria pipeline ...
Dupilumab improved HRQOL in patients with CSU who are omalizumab-naïve and have a substantial disease burden despite standard of care treatment.
Enter food therapy—a gentle, empowering approach that harnesses the power of everyday edibles to address root causes like ...
A rare condition means ice cubes, cold drinks and winter air can all trigger hives, swelling and even anaphylaxis.
Available on prescription and over the counter, fexofenadine is used for conditions such as hay fever, hives, eczema, ...
Nigeria needs about N36 billion to scale commercial honey and apiculture production, industry experts have said. The remark was made ...
Novartis CEO Vas Narasimhan is doubling down on a growth forecast for 2026, even as the Swiss drugmaker’s fourth-quarter ...
Oncodermatology is evolving with nonsurgical approaches and immune checkpoint inhibitors, improving outcomes in aggressive ...
Real-world and clinical trial data underscore long-term safety and effectiveness in pediatric and adult NPC patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results